134 related articles for article (PubMed ID: 15762006)
1. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
Spitzer WO
J Obstet Gynaecol Can; 2004 Jun; 26(6):549-50. PubMed ID: 15762006
[No Abstract] [Full Text] [Related]
2. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
Meltzer A
J Obstet Gynaecol Can; 2004 May; 26(5):457-8. PubMed ID: 15224669
[No Abstract] [Full Text] [Related]
3. Absolute and attributable risk of venous thromboembolism in women on combined cyproterone acetate and ethinylestradiol.
Lidegaard Ø
J Obstet Gynaecol Can; 2003 Jul; 25(7):575-7. PubMed ID: 12851669
[TBL] [Abstract][Full Text] [Related]
4. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
Pini M
J Obstet Gynaecol Can; 2004 Jul; 26(7):625; author reply 626. PubMed ID: 15329967
[No Abstract] [Full Text] [Related]
5. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
Spitzer WO
J Obstet Gynaecol Can; 2003 Dec; 25(12):1011-8. PubMed ID: 14663535
[TBL] [Abstract][Full Text] [Related]
6. Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report.
Nazli Y; Colak N; Aksoy ON; Cakir O
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):331-3. PubMed ID: 21415709
[TBL] [Abstract][Full Text] [Related]
7. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis.
Stegeman BH; de Bastos M; Rosendaal FR; van Hylckama Vlieg A; Helmerhorst FM; Stijnen T; Dekkers OM
BMJ; 2013 Sep; 347():f5298. PubMed ID: 24030561
[TBL] [Abstract][Full Text] [Related]
8. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.
Seaman HE; de Vries CS; Farmer RD
Hum Reprod; 2003 Mar; 18(3):522-6. PubMed ID: 12615818
[TBL] [Abstract][Full Text] [Related]
9. First-use risks.
Rowe TC
CMAJ; 2003 May; 168(11):1394. PubMed ID: 12771065
[No Abstract] [Full Text] [Related]
10. Diane-35 (cyproterone acetate): safety concerns.
Wooltorton E
CMAJ; 2003 Feb; 168(4):455-6. PubMed ID: 12591790
[No Abstract] [Full Text] [Related]
11. Oral contraceptive pills induced hemichorea in an adolescent female with polycystic ovarian disease.
Sharmila V; Babu TA
Indian J Pharmacol; 2015; 47(2):232-3. PubMed ID: 25878392
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary thromboembolism in primary care].
Esteban-Jiménez O; Velázquez-Lupiáñez L; Martínez-Raposo Piedrafita MC; Cebollada-Gracia AD
Semergen; 2013 Apr; 39(3):175-8. PubMed ID: 23540994
[TBL] [Abstract][Full Text] [Related]
13. Skin ulcers in a young woman on low-dose estrogen-combination pill.
Siregusa M; Alberti A; Schepis C
Int J Dermatol; 1997 Apr; 36(4):317-8. PubMed ID: 9169341
[No Abstract] [Full Text] [Related]
14. Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.
Seaman HE; de Vries CS; Farmer RD
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):427-36. PubMed ID: 15269926
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thrombosis varies with different types of combined oral contraceptives.
DeSancho MT
Evid Based Med; 2014 Apr; 19(2):e11. PubMed ID: 24288174
[No Abstract] [Full Text] [Related]
16. Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone-binding globulin levels in premenopausal women.
Stegeman BH; Raps M; Helmerhorst FM; Vos HL; van Vliet HA; Rosendaal FR; van Hylckama Vlieg A
J Thromb Haemost; 2013 Jan; 11(1):203-5. PubMed ID: 23122048
[No Abstract] [Full Text] [Related]
17. [Clarification concerning NuvaRing].
Jonsson M
Lakartidningen; 2007 Jan 31-Feb 6; 104(5):355. PubMed ID: 17328363
[No Abstract] [Full Text] [Related]
18. ACP Journal Club. Review: Combined oral contraceptives are associated with venous thrombosis.
Harper DM; Wilfling LE; Blanner CF
Ann Intern Med; 2013 Dec; 159(12):JC12. PubMed ID: 24343405
[No Abstract] [Full Text] [Related]
19. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
Gai L; Jia Y; Zhang M; Gai P; Wang S; Shi H; Yu X; Liu Y
Contraception; 2012 Oct; 86(4):332-6. PubMed ID: 22364818
[TBL] [Abstract][Full Text] [Related]
20. Drospirenone: high risk of venous thrombosis.
Prescrire Int; 2011 Feb; 20(113):43-5. PubMed ID: 21488592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
